Novo Nordisk’s next obesity battlefront: Winning beyond America
The weight loss pill had a strong U.S. launch this year, and Novo believes that will be replicated in other markets around the world.
Original Source
Read the full article at Cnbc →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.